PODD241115P280000
- 0.00
- 0.000.00%
Insulet Newsroom
Connected Drug Delivery Devices Market Forecast Report to 2035, Profiling Leading Companies Bigfoot Biomedical, BIOCORP, Eitan Medical, EoFlow, Insulet, Medtronic, Medtrum, Sonceboz, Ypsomed & More - ResearchAndMarkets.com
Earnings Preview: Insulet to Report Financial Results Post-market on November 07
$Insulet(PODD.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $Insulet(PODD.US)$ to post revenue of USD518.47M for 2024Q3, up 19.82%
Is Insulet Corporation's (NASDAQ:PODD) 40% ROE Better Than Average?
Express News | Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
Omnipod 5 App for iPhone Now Fully Available in the United States
(PODD) - Analyzing Insulet's Short Interest
Is Insulet Stock a Smart Addition to Your Portfolio Right Now?
Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others
Goldman's High Growth Investment Ratio Stocks: EA, AMZN, FANG, Etc
Insulet's Quarterly Earnings Preview: What You Need to Know
Is Now An Opportune Moment To Examine Insulet Corporation (NASDAQ:PODD)?
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
Insulet Is Maintained at Buy by BTIG
Raymond James Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $260
BTIG Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $260
Express News | Insulet Corp : Btig Raises Target Price to $260 From $250
Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?
We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
National Campaign Launches to Combat Diabetes Stigma Using Comedy
Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance